{"id":"W2108046961","doi":"10.1016/j.jaad.2003.10.010","title":"Efficacy and safety of efalizumab in a large cohort of patients with moderate to severe plaque psoriasis: pooled results from randomized phase III trials","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Plaque psoriasis; Internal medicine; Randomized controlled trial; Cohort; Dermatology; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001014145,0.0002383331,0.003201304,0.0002925739,0.00005303918,0.000002735678,0.0003407472,0.0002028207,0.0000146283],"category_scores_gemma":[0.0007875738,0.0001402092,0.000289439,0.0003045681,0.0005135363,0.00007969199,0.00008320675,0.0003146844,0.000001424007],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004314562,"about_ca_system_score_gemma":0.000154691,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000175814,"about_ca_topic_score_gemma":0.00001429102,"domain_scores_codex":[0.9953517,0.001894572,0.002156221,0.000214471,0.0001154099,0.0002676253],"domain_scores_gemma":[0.9941553,0.001649594,0.003861232,0.0001753337,0.0001103686,0.00004818036],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9665464,0.001233454,0.01181497,0.00001917722,0.004376128,0.00001282578,0.001847108,0.0003202892,0.01091419,0.0001552405,0.0001540462,0.0026062],"study_design_scores_gemma":[0.8264585,0.0006753429,0.08627126,0.0003465565,0.001956728,0.0002219592,0.0002512369,0.00000400157,0.08306597,0.0003787068,0.00017023,0.000199489],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995387,0.0009759089,0.0001647337,0.001874164,0.0001297606,0.0008549257,0.0005855946,0.000004403295,0.00002354242],"genre_scores_gemma":[0.9987277,0.0005296552,0.0004785498,0.0001889568,0.00001556824,0.00001030522,0.00002672214,0.00001361083,0.000008904781],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1400878,"threshold_uncertainty_score":0.5717564,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01287950324949974,"score_gpt":0.278769773733461,"score_spread":0.2658902704839613,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}